Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2-Reference-Cited by-同舟云学术

Angiotensin Converting Enzyme Inhibitors (ACEIs) Decrease the Progression of Cardiac Fibrosis in Rheumatic Heart Disease Through the Inhibition of IL-33/sST2

Published:2020-07-28 Issue: Volume:7 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Ambari Ade M.,Setianto Budhi,Santoso Anwar,Radi Basuni,Dwiputra Bambang,Susilowati Eliana,Tulrahmi Fadilla,Doevendans Pieter A.,Cramer Maarten J.

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference84 articles.

1. Rheumatic heart disease worldwide: JACC scientific expert panel;Watkins;J Am Coll Cardiol.,2018

2. The global burden of group A streptococcal diseases;Carapetis;Lancet Infect Dis.,2005

3. 35Health Statistics and Information Systems|Disease Burden and Mortality Estimates2018

4. The Drakensberg declaration on the control of rheumatic fever and rheumatic heart disease in Africa;Mayosi;S Afr Med J.,2006

5. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory;Carapetis;Med J Aust.,1996

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II and post-streptococcal glomerulonephritis;Clinical and Experimental Nephrology;2024-01-03

2. Roles of IL-33 in the Pathogenesis of Cardiac Disorders;Experimental Biology and Medicine;2023-10-12

3. A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the Gut;International Journal of Molecular Sciences;2023-08-31

4. Myocardial fibrosis in rheumatic heart disease: emerging concepts and clinical implications;Frontiers in Cardiovascular Medicine;2023-07-19

5. Topical captopril: a promising treatment for secondary lymphedema;Translational Research;2023-07